Analyst Ratings For Epizyme (NASDAQ:EPZM)
Today, Cann reiterated its Buy rating on Epizyme (NASDAQ:EPZM) with a price target of $26.00.
There are 11 buy ratings on the stock.
The current consensus rating on Epizyme (NASDAQ:EPZM) is Buy (Score: 3.00) with a consensus target price of $24.25 per share, a potential 45.21% upside.
Some recent analyst ratings include
- 11/2/2017-Cann Reiterated Rating of Buy.
- 9/20/2017-Jefferies Group LLC initiated coverage with a Buy rating.
- 9/19/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Buy.
- 9/15/2017-Royal Bank Of Canada Reiterated Rating of Buy.
- 8/9/2017-Leerink Swann Reiterated Rating of Outperform.
- 8/7/2017-HC Wainwright Reiterated Rating of Buy.
Recent Insider Trading Activity For Epizyme (NASDAQ:EPZM)
Epizyme (NASDAQ:EPZM) has insider ownership of 25.20% and institutional ownership of 72.20%.
- On 10/24/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $16.44 per share and the total transaction amounting to $246,600.00. View SEC Filing
- On 9/25/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $16.81 per share and the total transaction amounting to $252,150.00. View SEC Filing
- On 9/18/2017 David M Mott, Director, bought 200,000 with an average share price of $15.25 per share and the total transaction amounting to $3,050,000.00. View SEC Filing
- On 8/24/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $15.68 per share and the total transaction amounting to $235,200.00. View SEC Filing
- On 7/24/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $13.44 per share and the total transaction amounting to $201,600.00. View SEC Filing
- On 6/30/2017 Andrew E Singer, CFO, sold 3,024 with an average share price of $15.50 per share and the total transaction amounting to $46,872.00. View SEC Filing
- On 6/26/2017 Peter Tai-Ching Ho, Insider, sold 15,000 with an average share price of $14.87 per share and the total transaction amounting to $223,050.00. View SEC Filing
Recent Trading Activity for Epizyme (NASDAQ:EPZM)
Shares of Epizyme closed the previous trading session at with shares trading hands.